Clinical trial
Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell…
NCT00006004 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006004 |
|---|---|
| Title | Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer |
| Official title | A Randomized Phase II Trial of Paclitaxel-Carboplatin or Gemicitabine-Cisplatin in ECOG Performance Status 2 Non-Small Cell Lung Cancer Patients |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, gemcitabine hydrochloride, paclitaxel |
| Start date | Aug 22, 2000 |
| Primary completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 15, 2023 |
| Countries | Australia, Peru, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: